Loading provider…
Loading provider…
Rheumatology Physician in Cincinnati, OH
NPI: 1386635431Primary Practice Location
WEST CHESTER HOSPITAL
7750 Discovery Dr, West Chester, OH
Primary Employer
University of Cincinnati Physicians Company, LLC
ucphysicians.com
HQ Phone
Get MD Michael's Phone Numberphone_androidMobile
Get MD Michael's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 114 | 241 |
| 2 | 99213Established patient office or other outpatient visit, typically 15 minutes | 93 | 152 |
| 3 | 96365Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour | 31 | 97 |
| 4 | J7030Infusion, normal saline solution , 1000 cc | 25 | 69 |
| 5 | 96415Infusion of chemotherapy into a vein | 24 | 54 |
Cognitive dysfunction in patients with systemic lupus erythematosus: a controlled study.
Authors: Marc Antonchak, Hermine Brunner, Mahnaz Saoudian
Publication Date: 2011-04-05
Cognitive dysfunction in SLE: development of a screening tool.
Authors: Adhikari, T, Piatti, A, Luggen, M
Journal: Lupus
Publication Date: 2011-06-15
Longterm safety and efficacy of abatacept through 5 years of treatment in patients with rheumatoid arthritis and an inadequate response to tumor necrosis factor inhibitor therapy.
Authors: Mark Genovese
Publication Date: 2012-07-17
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: DRUG: Placebo, BIOLOGICAL: GSK3196165 (Otilimab), DRUG: Tofacitinib 5 mg
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: BIOLOGICAL: Otilimab (GSK3196165), DRUG: csDMARD(s)
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: DRUG: csDMARDs, BIOLOGICAL: GSK3196165 (Otilimab), BIOLOGICAL: Sarilumab, DRUG: Placebo to GSK3196165/ Sarilumab